non-invasive patient screening News
-
BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen
BillionToOne , Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new addition to UNITY Screen. For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT ...
-
BillionToOne to present single-gene NIPT poster at 40th SMFM conference
BillionToOne is presenting a poster on UNITY‘s single-gene NIPT at the 40th Annual Pregnancy Meeting by Society of Maternal Fetal Medicine. A non-invasive prenatal test for Alpha Thalassemia Hb Barts and Hb Constant Spring UNITY is the only prenatal screen that tests cell-free fetal DNA for cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease, and alpha and beta ...
-
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly, preparation-free, screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you